News & Perspective

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Jun 23, 2011

Jun 23, 2011

New E coli reports leave major questions hanging

(CIDRAP News) – A spate of new reports on Germany's huge outbreak of enterohemorrhagic Escherichia coli (EHEC) is emphasizing the idea that the strain is unusually virulent, but the latest findings leave major questions about the outbreak unanswered.

Jun 06, 2011

Jun 06, 2011

Initial tests negative for outbreak E coli in German sprouts

(CIDRAP News) – German authorities investigating a possible sprout link to a large Escherichia coli outbreak said today that lab samples are negative so far, dashing hopes for a quick end to the investigation and adding more confusion to the search for the source.

Jun 05, 2011

Jun 05, 2011

Sprouts linked to European E coli outbreak

(CIDRAP News) – German officials today announced that they have tentatively linked bean sprouts grown in the northern part of the country to a massive Escherichia coli outbreak, a development that US experts say could help explain some of the outbreak's puzzling elements.

May 27, 2011

May 27, 2011

Questions abound in European E coli outbreak

(CIDRAP News) – Questions abounded today concerning the large and growing outbreak of Escherichia coli infections concentrated in northern Germany, including where it came from, why it is striking mostly women, and why the number of reported hemolytic uremic syndrome (HUS) cases, at 276, is so unusually high.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

Jan 13, 2010

Jan 13, 2010

Health officials, experts reject 'false pandemic' charges

(CIDRAP News) – Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.

Sep 22, 2009

Sep 22, 2009

Pandemic flu experts share preparedness perspectives with businesses

(CIDRAP News) – With so much uncertainty over how broad and severe the next wave of H1N1 influenza could be, now is the time to focus on the two top goals of saving and sustaining lives, Dr. Julie Gerberding, former director of the US Centers for Disease Control and Prevention (CDC), told business groups today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»